Latest Breaking News On - Ceptur therapeutics inc - Page 1 : comparemela.com

NLS Pharmaceutics Appoints Keith Harrison Dewedoff as Interim Chief Financial Officer

NLS Pharmaceutics Appoints Keith Harrison Dewedoff as Interim Chief Financial Officer
newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.

Marianne lambertsonKaizen bioscienceAlex zwyerKeith harrison dewedoffExchange commissionCode biotherapeutics incKellogg collegeDrug administrationPharmaceutics ltdNortheastern universityEuropean medicines agencyAdvisor for danforth advisorsCeptur therapeutics incVillanova universityInvestments wealth instituteInterim chief financial officer

NLS Pharmaceutics AG: NLS Pharmaceutics Appoints Keith Harrison Dewedoff as Interim Chief Financial Officer

ZÜRICH, SWITZERLAND / ACCESSWIRE / May 8, 2023 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and

Alex zwyerKeith harrison dewedoffMarianne lambertsonKaizen bioscienceKellogg collegePharmaceutics ltdNortheastern universityCeptur therapeutics incVillanova universityDrug administrationCode biotherapeutics incAdvisor for danforth advisorsInvestments wealth instituteEuropean medicines agencyExchange commissionInterim chief financial officer

Ceptur Therapeutics Raises $75M in Series A Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Colin walshCeop peter ghoroghchianAaron roystonCeptur therapeutics incBristol myers squibbCeptur therapeuticsHillsborough new jersey basedBio partnersQiming venture partners united statesPerceptive xontogeny ventureJanus henderson investorsAffinity asset advisorsBoxer capitalLifesci ventureManaging partner